MARKET

ADAG

ADAG

Adagene Inc.
NASDAQ
1.890
+0.074
+4.07%
After Hours: 1.890 0 0.00% 16:10 12/31 EST
OPEN
1.810
PREV CLOSE
1.816
HIGH
1.900
LOW
1.800
VOLUME
51.19K
TURNOVER
--
52 WEEK HIGH
3.160
52 WEEK LOW
1.300
MARKET CAP
89.08M
P/E (TTM)
-2.9362
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADAG last week (1222-1226)?
Weekly Report · 12/29/2025 10:13
Weekly Report: what happened at ADAG last week (1215-1219)?
Weekly Report · 12/22/2025 10:13
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug
NASDAQ · 12/17/2025 13:43
Adagene, Palvella gain after FDA Fast Track Designations
Seeking Alpha · 12/16/2025 14:24
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Novan (NOVN) and Adagene (ADAG)
TipRanks · 12/16/2025 13:20
Why Adagene Is Rising In Pre-market?
NASDAQ · 12/16/2025 12:30
Adagene announces FDA fast track designation for muzastotug
TipRanks · 12/16/2025 12:05
Weekly Report: what happened at ADAG last week (1208-1212)?
Weekly Report · 12/15/2025 10:20
More
About ADAG
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.

Webull offers Adagene Inc (ADR) stock information, including NASDAQ: ADAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADAG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADAG stock methods without spending real money on the virtual paper trading platform.